Back to top

BMRN Maintained by Canaccord Genuity -- Price Target Raised to $114

BMRN Maintained by Canaccord Genuity -- Price Target Raised to $114

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioMarin Pharmaceutical Inc. (BMRN)